期刊文献+

ECRG4: a new potential target in precision medicine

收藏 分享 导出
摘要 Given the rapid development in precision medicine, tremendous efforts have been devoted to discovering new biomarkers for disease diagnosis and treatment. Esophageal cancer-related gene-4 (ECRG4),which is initially known as a new candidate tumor suppressor gene, is emerging as a sentinel molecule for gauging tissue homeostasis. ECRG4 is unique in its cytokine-like functional pattern and epigenetically-regulated gene expression pattern. The gene can be released from the cell membrane upon activation and detected in liquid biopsy, thus offering considerable potential in precision medicine. This review provides an updated summary on the biology of ECRG4, with emphasis on its important roles in cancer diagnosis and therapy. The future perspectives of ECRG4 as a potential molecular marker in precision medicine are also discussed in detail.
出处 《医学前沿:英文版》 CAS CSCD 2019年第5期540-546,共7页 Frontiers of Medicine
基金 the Major Program Development Project of the National Natural Science Foundation of China (No.30600492) the Natural Science Foundation of Shaanxi Province (No.2016JM 3010) Xiangyang Science and Technology (Intellectual Property) Bureau (2016 file No.73) the Natural Science Foundation of Hubei Province (No.2014CFC1154) the Teachers’ Scientific A bility Cultivation Foundation of Hubei University of Arts and Science (No.2017KYPY004).
作者简介 Correspondence:Ping Zhang,pingzhang0622@126.com.
  • 相关文献
投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈